Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threat
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By Type
6.1 Contraceptive Devices
6.1.1 Vaginal Rings
6.1.2 Sponges
6.1 3 Cervical Caps
6.1.4 Diaphragms
6.1.5 Condoms
6.2 Implants
6.3 IUD
Chapter 7 Market Segmentation, By Gender
7.1 Male
7.2 Female
Chapter 8 Market Segmentation, By Geography
8.1 Introduction
8.2 Brazil
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company Profiles
10.1. Actavis, Inc
10.2. Bayers AG
10.3. Merck & Co., Inc.
10.4. Teva Pharmaceutical Industries Ltd.
10.5. Mylan Laboratories
10.6. The Female Health Company
10.7. Reckitt Benckiser Group, PLC
10.8. Okamato Industries, Inc.
10.9. Lupin Pharmaceuticals, Ltd
10.10. Johnson & Johnson, Ltd
10.11. Fuji Latex Co., Ltd
10.12. Church & Dwight, Co. Inc.
10.13. ANI Pharmaceuticals, Inc.
10.14. Agile Therapeutics
10.15. Pfizer
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
